导航欧盟临床试验:适应法规的新时代
Stéphanie Kromar1, Rana Kassas1
1EORTC, Avenue E. Mounier, 83, Brussels 1200, Belgium.
Journal of cancer policy
|February 17, 2025
概括
新的欧盟 (EU) 医疗保健法规给临床试验带来了复杂的合规挑战,影响了研究和创新. 解决这些监管障碍对于整合进展和使患者受益至关重要.
科学领域:
- 医疗保健政策和监管 医疗保健政策和监管
- 临床试验的管理管理.
- 医疗创新是医学上的创新.
背景情况:
- 欧盟 (EU) 成员国已出台新的医疗保健法规,以规范实施.
- 这些法规旨在维护医疗保健创新的高道德和科学标准.
- 同时将多个欧盟法规应用于临床试验提出了重大挑战.
研究的目的:
- 探索临床研究中重叠但不同的欧盟法规之间的相互作用.
- 确定医疗保健利益相关者,特别是临床试验赞助商的合规复杂性.
- 解决新监管环境对临床研究计划造成的行政和财务负担.
主要方法:
- 分析多个欧盟医疗保健法规的范围和要求.
- 检查对临床试验赞助商和医疗保健利益相关者的影响.
- 审查正在进行的泛欧倡议,以应对监管复杂性.
主要成果:
- 欧盟法规通常在范围上重叠,但在要求上有所不同,导致合规复杂性.
- 临床研究项目面临着增加的行政和财务负担.
- 在目前的监管框架下,将技术进步纳入医疗保健系统存在挑战.
结论:
- 解决监管复杂性对于在医疗保健中安全有效地整合技术进步至关重要.
- 在泛欧一级正在进行协调努力,以管理涉及药物和设备的试验的不同工作流程.
- 欧洲癌症研究和治疗组织 (EORTC) 积极参与欧盟倡议,以应对癌症研究的挑战.
相关概念视频
Clinical Trials: Overview
2.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.7K
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Preclinical Development: Overview
4.2K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.2K
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
112
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
112
Pharmacovigilance
768
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
768


